Index by author

April 01, 2002; Volume 69,Issue 4 suppl 2

Proceedings of the 10th International Vasculitis and ANCA Workshop

  1. Hoffman, G

    1. Genetic Resistance to Wegener’s Granulomatosis—A Role for CCR5 in Patients Without Antineutrophil Cytoplasmic Antibodies
      Y Zhou, D Huang, C Farver and G Hoffman
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;

  2. Hoffman, GS

    1. Genetic Polymorphisms in TNF, IL-1, IL-6 And Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Wegener’s Granulomatosis (WG)
      Y Zhou, D Huang and GS Hoffman
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;

  3. Hoffman, Gary S.

    1. Treatment of giant-cell arteritis: where we have been and why we must move on
      Gary S. Hoffman, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII117-SII120;

  4. Hogan, SL

    1. Increases of PR3 and MPO Gene Transcription in Circulating Leukocyte of Anca-Associated Disease Correlate with Disease Activity
      JJ Yang, GA Preston, DA Alcorta, BD Phillips, RP Thomas, SL Hogan, JC Jennette and RJ Falk
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103;

  5. Hsieh, Y-H

    1. Chlamydia Pneumoniae and Giant-Cell Arteritis: Failure to Detect Chlamydia Pneumoniae in Temporal Artery Biopsies by Polymerase Chain Reaction in 90 Cases and 90 Controls
      MJ Regan, BJ Wood, Y-H Hsieh, ML Theodore, TC Quinn, DB Hellmann, WR Green, CA Gaydos and JH Stone
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;

  6. Hu, P

    1. Induction of Necrotizing and Crescentic Glomeru-Lonephritis (NCGN) and Small-Vessel Vasculitis (SVV) by Adoptive Transfer of Anti-Myeloperoxidase (Anti-MPO) Lymphocytes into Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice
      H Xiao, P Heeringa, Z Liu, P Hu, M Zhao, Y Aratani, RJ Falk and JC Jennette
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
    2. Induction of Pauci-Immune Necrotizing and Crescen-Tic Glomerulonephritis (NCGN) by Intravenous Administration of Anti-Myeloperoxidase (Anti-MPO) Antibodies to Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice
      JC Jennette, H Xiao, P Heeringa, Z Liu, P Hu, M Zhao, Y Aratani and RJ Falk
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;

  7. Huang, D

    1. Genetic Resistance to Wegener’s Granulomatosis—A Role for CCR5 in Patients Without Antineutrophil Cytoplasmic Antibodies
      Y Zhou, D Huang, C Farver and G Hoffman
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
    2. Genetic Polymorphisms in TNF, IL-1, IL-6 And Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Wegener’s Granulomatosis (WG)
      Y Zhou, D Huang and GS Hoffman
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;

  8. Hunder, Gene G.

    1. Epidemiology of giant-cell arteritis
      Gene G. Hunder, MD
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-79-SII-82;

  9. Ishida-okawara, A

    1. Contribution of Activated Neutrophils and Mpo-Anca to the Development of Crescentic Glomeru-Lonephritis in Scg/Kj Mice
      A Ishida-Okawara, T Ito-Ihara, T Ono, E Muso, K Saiga, K Nemoto and K Suzuki
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13-SII-14;

  10. Ito-ihara, T

    1. Contribution of Activated Neutrophils and Mpo-Anca to the Development of Crescentic Glomeru-Lonephritis in Scg/Kj Mice
      A Ishida-Okawara, T Ito-Ihara, T Ono, E Muso, K Saiga, K Nemoto and K Suzuki
      Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13-SII-14;
« Previous (Pages : 2 3 4 5 6 7 8 9 10 11 ... 15) Next »
Back to top

In this issue